The FDA review affirmed results from Pfizer posted earlier in the day showing the two-dose shot was nearly 91% effective at preventing symptomatic infection in young children. Children could begin vaccinations early next month - with the first youngsters in line fully protected by Christmas.įull-strength Pfizer shots already are recommended for anyone 12 or older, but pediatricians and many parents are anxiously awaiting protection for younger children to stem infections from the extra-contagious delta variant and help keep kids in school. If the FDA authorizes the shots, the Centers for Disease Control and Prevention will make additional recommendations on who should receive them the first week of November.
The agency will put that question to its panel of independent advisers next Tuesday and weigh their advice before making its own decision.
Study: The unvaccinated could catch COVID every 16 months
0 kommentar(er)
